Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
  • C07D209/04—Indoles; Hydrogenated indoles
  • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
  • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
  • C07D209/56—Ring systems containing three or more rings
  • C07D209/58—[b]- or [c]-condensed
  • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
  • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
  • C07F9/02—Phosphorus compounds
  • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
  • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
  • C07F9/572—Five-membered rings
  • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
  • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
  • C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
  • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
  • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
  • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
  • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
  • C12Q2563/149—Particles, e.g. beads

Definitions

• the invention relates generally to cyanine dyes and specifically to cyanine dye phosphoramidites, their synthesis and methods of use in labeling of oligonucleotides. Description of the Prior Art
• Oligonucleotides of a desirable sequence are synthesized by coupling nucleosides through phosphorous-containing covalent linkages.
• the most commonly used oligonucleotide synthesis method involves reacting a nucleoside with a protected cyanoethyl phosphoramidite monomer in the presence of a weak acid; oxidation of the formed phosphite linkage; and hydrolysis of the cyanoethyl group (Advances in the Synthesis of Oligonucleotides by the Phosphoramidite Approach, Beaucage, S. L.; Iyer, R. P., Tetrahedron, 1992, 48, 2223-2311).
• Cyanine dyes offer many desirable properties, including safe handling, absorbency at longer wavelengths, high extinction coefficient, relatively high quantum efficiency, small molecular size, ease of chemical manipulation, and reasonable stability to reagents, pH and temperature. Because of a low background fluorescence of biological materials and a high absorbency of cyanine dyes in the longer wavelength portion of the spectrum, cyanine dyes provide excellent signal-to-noise ratios. By synthesizing structural modifications of the chromophore portion of cyanine dyes, different fluorescent labeling reagents absorbing and emitting in a broad spectrum range from 400 to nearly 1100 nm can be obtained.
• labeling of oligonucleotides with cyanine dyes is performed by a manual, two-step procedure.
• an oligonucleotide is synthesized and, then, an activated cyanine dye is linked to the 5' end of the synthesized oligonucleotide.
• cyanine dyes are activated by an introduction of reactive groups that assist in covalent attachment of cyanine dyes to oligonucleotides (see, for example, U.S. Pat. Nos. 5,569,587 and 5,627,027).
• This two-step method is slow (4-5 days), tedious, expensive, and often produces undesirable organic by-products.
• a fluorescent dye is converted into a phosphoramidite and is used in direct labeling of an oligonucleotide during its synthesis.
• phosphoramidites of cyanine dyes are substantially more expensive and less stable than their standard, unmodified counterparts.
• U.S. Pat. No. 5,556,959 discloses the use of carbocyanine phosphoramidites to label synthetic oligonucleotides.
• the cyanine phosphoramidites of the '959 patent contain protecting groups, such as trityl; 4-O-monomethoxytrityl; 4,4'-O-dimethoxytrityl or acyl.
• protecting groups are usually associated with instability during storage and handling, thus making these phosphoramidites less valuable commercially.
• an object of the present invention to provide stable cyanine dye phosphoramidites for direct labeling of oligonucleotides during their automated synthesis on DNA synthesizers. It is also an object of the present invention to provide convenient methods for synthesizing phosphoramidites that do not require steps of introduction and removal of protecting groups. It is a further object of the present invention to provide a method for labeling an oligonucleotide directly during its synthesis.
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group consisting of S, O, N, CH and phosphoramidite group;
• X is a negative ion; and
• Q is wherein n is 1, 2, or 3.
• the dye is a cyanine dye selected from the group consisting of Cy5, benz Cy5, dibenz Cy5, Cy7, benz Cy7, dibenz
• the phosphoramidite group may be a N,N-diisopropyl-O- ⁇ -cyanoethyl phosphoramidite group.
• Another aspect of the present invention provides a method of synthesizing a dye phosphoramidite.
• the method includes the steps of: (a) forming a hydroxy derivative of the dye having a formula:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring
• m is an mteger from 1 to 18
• Y and Z are independently selected ⁇ from the group consisting of S, O, N, CH 2 and C(CH 3 )
• Ri is an alkyl
• X is a negative ion
• Q is , wherein n is 1, 2 or 3; and (b) replacing hydrogen of the OH group with a phosphoramidite group.
• the dye can be a cyanine dye, and particularly Cy5, benz Cy5, dibenz Cy5, Cy7, benz Cy7, dibenz Cy7, cyclic Cy7, cyclic benz Cy7, or cyclic dibenz Cy7.
• the phosphoramidite group maybe aN,N-diisopropyl-O- ⁇ - cyanoethyl phosphoramidite giOUp.
• the step of forming a hydroxy derivative of the dye (II) comprises reacting compounds (XI), (XII) and (XIII) under conditions that allow formation of the hydroxy derivative of the cyanine dye.
• Compound (XI) may be any compound having a general formula:
• Compound (XI1T) may be any compound having a general formula:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group consisting of S, O, N, CH 2 and C(CH 3 ) 2 ;
• Ri is an alkyl; and
• X is a negative ion.
• the step of forming a hydroxy derivative of the dye may comprise:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group consisting of S, O, N, CH and C(CH 3 ) 2 ;
• Ri is an alkyl;
• X is a negative ion; and
• Q is , wherein n is 1 or 2 and R 2 is a halogen or
• a further aspect of the present invention provides a method wherein luminescent dye phosphoramidites are used to label oligonucleotides directly.
• the present invention provides both economic and technical advantages over the use of other dyes in the labeling of biopolymers, especially oligonucleotides.
• dye phosphoramidites of this invention can be used directly on any DNA synthesizer, for example, oligo 1000M (Beckman Coulter, CA), to automatically add the dye to the oligonucleotide during its synthesis.
• FIGS. 1A, IB, and 1C schematically illustrate methods of synthesis of dye phosphoramidites of the present invention
• Figure 2 shows a reaction scheme, illustrating synthesis of Cy5 phosphoramidites of the present invention
• Figure 3 shows a reaction scheme, illustrating synthesis of DBCy5 phosphoramidite of the present invention
• Figure 4 depicts 31 P NMR spectra of the DBCy5 phosphoramidite obtained according to the reaction scheme of Figure 3;
• Figure 5 shows a reaction scheme, illustrating synthesis of DBCy7 phosphoramidite of the present invention
• Figure 6 depicts 31 P NMR spectra of the DBCy7 phosphoramidite obtained according to the reaction scheme of Figure 5;
• Figure 7 shows a reaction scheme, illustrating synthesis of cyclic Cy7 phosphoramidite of the present invention
• Figure 8 shows a reaction scheme, illustrating synthesis of cyclic DBCy7 phosphoramidite of the present invention
• Figure 9 shows a reaction scheme, illustrating synthesis of Cy5 phosphoramidite of the present invention
• Figure 10 depicts 31 P NMR spectra of the Cy5 phosphoramidite obtained according to the reaction scheme of Figure 9;
• Figure 11 shows a reaction scheme, illustrating synthesis of DBCy5 phosphoramidite of the present invention
• Figure 12 depicts 31 P NMR spectra of the DBCy5 phosphoramidite obtained according to the reaction scheme of Figure 11 ;
• Figure 13 shows a reaction scheme, illustrating synthesis of cyclic Cy7 phosphoramidite of the present invention
• Figure 14 depicts 31 P NMR spectra of the cyclic Cy7 phosphoramidite obtained according to the reaction scheme of Figure 13;
• Figures 15(A) and 15(B) show HPLC chromatograms of an oligonucleotide labeled with the dye phosphoramidite of the present invention before ( Figure 15 (A)) and after ( Figure 15 (B)) purification.
• the present invention provides a dye phosphoramidite, having a formula:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group alkyl;
• (PAM) is a phosphoramidite gro
• the activated dyes can contain a heterocyclic ring, a single ring aromatic structure, such as a phenyl ring, or a fused ring structure, such as a naphthyl ring.
• the alkyl group generally possesses one to eighteen carbon atoms, preferably two carbon atoms.
• the phosphoramidite group is usually attached to the dye with an alkyl chain.
• the length of the alkyl chain is preferably about 1 to 12 carbon atoms long. The most practical alkyl chain length is about 6 carbon atoms long.
• the Compound (I) of the present invention includes a ⁇ negative ion X.
• this ion is a halide, although other negative ions may be used.
• the negative ion may be I or Br , depending on the synthesis strategy.
• the phosphoramidite group may be a N,N-diisopropyl-O- ⁇ -cyanoethyl phosphoramidite group, although other phosphoramidite known to one skilled in the art may also be used.
• the dyes of the present invention can be any of the fluorescent dyes commonly used for labeling purposes, as long as they incorporate a phosphoramidite group and an alkyl group. It is also required that the phosphoramidite group and the alkyl group are attached to nitrogens in the indole or benzoindole portion of the dye.
• the absorption and emission wavelengths of the dye are not restricted to a particular region of the spectrum but may be anywhere from the near UN through the near IR region or beyond these extremes.
• the dyes may be cyanine and related dyes.
• Cyanine dyes have several desirable properties to serve as sensitive detection labels, including absorption at longer wavelengths (which translates into the use of inexpensive detection systems and low background from biological samples at these wavelengths), high extinction coefficient, relatively high quantum efficiency, small molecular size, ease of chemical manipulation without compromising the fluorescence characteristics, and reasonable stability to reagents, pH and temperature.
• the cyanine dyes have a general structure where the chromophore of the cyanine dyes is composed of a series of conjugated double bonds, having two quaternary nitrogen atoms at the terminal ends which share one positive charge.
• phosphoramidites of dicarbocyanine dyes (Cy5, benz Cy5 (BCy5) and dibenz Cy5 (DBCy5)) and tricarbocyanine dyes (Cy7, benz Cy7 (BCy7) and dibenz Cy7 (DBCy7)) are used for direct labeling.
• the difference between these two groups of dyes is the presence of an additional double bond in Cy7, BCy7, and DBCy7 relative to Cy5, BCy5, and DBCy5, respectively. Consequently, the dicarbocyanine dyes have absorption and emission maxima about 100 nm shorter than their tricarbocyanine counterparts.
• benzoindole cyanines BCy5 and BCy7
• DBCy5 and DBCy7 have two extra benzene group substitutions relative to the corresponding indole cyanines, Cy5 and Cy7.
• benzoindole cyanines have absorption and emission maxima longer than their indole counterparts.
• phosphoramidites of cyclic Cy7 and DBCy7 dyes are utilized. It is a discovery of the present invention that the introduction of a cyclic moiety into the chain of conjugated double bonds of cyanine dye molecules provides an extra stability to Cy7 species.
• cyclic moiety having the following structure may be used:
• the dye phosphoramidites of the present invention can be used directly on any DNA synthesizer to automatically add the dye to the oligonucleotide.
• the dye phosphoramidites of this invention do not contain any protecting groups, which makes them more stable.
• the total time for the preparation of a labeled oligonucleotide is greatly reduced, since the step of removing a protecting group is eliminated, addition to cost and time saving provided by utilizing dye phosphoramidites of this invention for labeling of oligonucleotides, higher over-all yield of labeled product is also achieved as compared to the conventional two-step method.
• Another aspect of the present invention provides a method of synthesizing a dye phosphoramidite.
• the general synthetic scheme for the preparation of a dye phosphoramidite of the present invention is shown in Figures lA-lC.
• the method includes the steps of: (a) forming a hydroxy derivative of the dye (II), having a formula:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring; m is an integer from 1 to 18; Y and Z are independently selected
• Ri is an alkyl
• X is a negative ion
• Q is , wherein n is 1, 2 or 3;
• the dyes can contain a heterocyclic ring, a single ring aromatic structure, such as a phenyl ring, or a fused ring structure, such as a naphthyl ring.
• a heterocyclic ring a single ring aromatic structure, such as a phenyl ring, or a fused ring structure, such as a naphthyl ring.
• cyanines discussed above, including Cy5, BCy5, DBCy5, Cy7, BCy7, DBCy7, cyclic Cy7, cyclic BCy7, and cyclic DBCy7.
• the hydroxy derivative of the dye (II) is reacted with a suitable reagent under conditions that are sufficient to form a dye phosphoramidite (I).
• suitable reagents for replacing hydrogen with a phosphoramidite group include, but are not limited to, a mixture of tetrazole with (tPr 2 N) 2 PO-CH 2 -CH 2 -CN.
• Other reagents, such as zPr 2 N-P(Cl) OCH 2 CH 2 CN may also be used.
• this reaction may preferably be carried out at -20°C and under inert atmosphere.
• the step (a) of forming a hydroxy derivative of a cyanine dye may be carried out in two alternative ways, as shown in Figures IB and lC.
• the step of forming a hydroxy derivative of the cyanine dye involves reacting compounds (XI), (XII) and (XIII) under conditions that allow the formation of the hydroxy derivative of the cyanine dye.
• Compound (XI) may be any compound having a general formula:
• Compound (XII) may be any compound with a general formula: Ph-R 3 -Ph, wherein
• Ph is phenyl
• R 3 is:
• Compound (XIII) may be any compound with a general formula:
• Each dotted line in the above formulas represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring.
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group consisting of S, O, N, CH 2 and C(CH 3 ) 2 ;
• Ri is an alkyl;
• X® is a negative ion.
• the negative ion is a bromide.
• Compounds (XI), (XII), and (XITI) depends on the type of the dye phosphoramidite to be synthesized.
• a Cy5 phosphoramidite one may use Compound (Xlla) and unsubstituted Compounds (XI) and (XIII) ( Figure 2).
• Compound (XIIc) for synthesis of cyclic Cy7 phosphoramidite, one may use Compound (XIIc) and unsubstituted Compounds (XI) and (XIII) ( Figure 7).
• Compound (Xlla) and benz-substituted Compounds (XI) and (XIII) may be employed ( Figure 3).
• cyclic DBCy7 phosphoramidite may be synthesized by utilizing benz-substituted Compounds (XI) and (XIII) and Compound (XIIc) ( Figure 8).
• XI benz-substituted Compounds
• XIIc Compound (XIIc)
• Compound (XI) is 1 -ethyl 2,3,3- trimethyl- (3H)-indolinium iodide and Compound (XIII) is l-(6-hydroxyhexyl)-l, 1,2- trimethyl-(3H)-indolinium bromide.
• Compound (XIII) is l-(6-hydroxyhexyl)-l, 1,2- trimethyl-(3H)-indolinium bromide.
• Compound (XI) is 1 -ethyl 1, 1,2-trimethyl-H- Benz(e)indolinium iodide and Compound (XIII) is l-(6-hydroxyhexyl)-l, 1,2-trimethyl-H- Benz(e)indolinium bromide.
• phosphoramidites of benzene-substituted cyanine dyes such as DBCy5 ( Figure 3), DBCy7 or cyclic DBCy7 ( Figure 8) are synthesized.
• DBCy5 Figure 3
• DBCy7 or cyclic DBCy7 ( Figure 8)
• Compound (Xlla) is used, a phosphoramidite of DBCy5 is obtained.
• Compound (Xllb) a phosphoramidite of DBCy7 is produced and, with Compound (XIIc), a phosphoramidite of cyclic DBCy7 is formed.
• Compound (XIII) is formed by reacting Compound (XIN) with Br(CH 2 ) m -OH under reaction conditions that allow the formation of Compound (XIII).
• Compound (XIN) can be any compound having a general formula:
• the dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring.
• Y is selected from the group consisting of S, O, ⁇ , CH 2 and C(CH ) 2 ; and m is an integer from 1 to 18.
• Compound (XIN) is lJ,2-trimethyl-(3H)-indole or lJ,2-trimethyl-H-Benz(e)-indole, correspondingly.
• Different reaction conditions may be used as long as they allow the formation of the Compound (XIN).
• the reactions shown in Figures 2 and 3 were carried out at 125°C.
• the successful synthesis of the hydroxy derivative of a dye also depends on reaction conditions.
• Compound XI and Compound XII are heated in acetic anhydride and acetic acid for 30 minutes at 125°C.
• the resulting intermediate is evaporated to dryness and washed three times with 50 ml of diethyl ether and then reacted with Compound XIII in pyridine at 125°C for 30 minutes.
• Examples 1 and 2 provide further details on suitable reaction conditions.
• Other reaction conditions may be also used as long as they support the formation of the hydroxy derivative (II).
• Li an alternative method one may synthesize hydroxy derivative of the dye (11) in accordance with the method shown in Figure IC. The method comprises:
• each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are ⁇ independently selected from the group consisting of S, O, N, CH 2 and C(CH 3 ) 2 ;
• R ⁇ is an , wherein n is 1 or
• the negative ion is I .
• the dyes can contain a heterocyclic ring, a single ring aromatic structure, such as a phenyl ring, or a fused ring structure, such as a naphthyl ring.
• cyanines discussed above, including Cy5, BCy5, and DBCy5, cyclic Cy7, cyclic BCy7, and cyclic DBCy7.
• step (al) of forming an acetoxy derivative of the dye (XX) includes reacting compounds (XI), (XXII) and (XXHI) under conditions that allow the formation of the acetoxy derivative of the cyanine dye.
• Compound (XI) may be any compound having a general formula:
• Ph is phenyl
• Compound (XXIII) may be any compound with a general formula:
• Each dotted line represents carbon atoms necessary to form a fused substituted or unsubstituted aromatic ring;
• m is an integer from 1 to 18;
• Y and Z are independently selected from the group consisting of S, O, N, CH and C(CH 3 ) ;
• Ri is an alkyl; and
• X ⁇ is a negative ion. h one embodiment, the negative ion is 1° .
• (XI), (XXII), and (XXIII) depends on the type of the dye phosphoramidite to be synthesized.
• XXIIa Compound (XXIIa) and unsubstituted Compounds (XI) and (XXIII)
• Figure 9 For synthesis of cyclic Cy7 phosphoramidite, one may use Compound (XXIIb) and unsubstituted Compounds (XI) and ⁇ " v ⁇ m c p i ⁇ nr p 1 ⁇ Tr.
• Compound (XI) is 1-ethyl 2,3,3- trimethyl- (3H)-indolinium iodide and Compound (XXIII) is l-(l'-acetoxypropyl)-2, 3,3'- trimethyl-(3H)-indolinium iodide, h this embodiment, depending on the type of Compound (XXII) used, phosphoramidites of unsubstituted cyanine dyes, such as Cy5 ( Figure 9) or cyclic Cy7 ( Figure 13), are obtained. When Compound (XXIIa) is used, a phosphoramidite of Cy5 is obtained. Similarly, with Compound (XXIIb), a phosphoramidite of cyclic Cy7 is produced.
• Compound (XI) is 1-ethyl 1, 1,2-trimethyl-H- Benz(e)indolinium iodide and Compound (XXIII) is l-(l'-acetoxypropyl)-2, 3,3'-trimethyl- H-Benz(e)indolinium iodide.
• phosphoramidites of benzene-substituted cyanine dyes such as DBCy5 ( Figure 11) or cyclic DBCy7 (not shown) are synthesized.
• DBCy5 Figure 11
• cyclic DBCy7 not shown
• acetoxy derivative of the dye in accordance with the method depicted in Figure IC, also depends on reaction conditions.
• Compounds XI and XXII are incubated in a mixture of acetic acid (20 ml) and acetic anhydride (20 ml) in an oil bath at 120°C for 2 hr. The solvents are removed with a rotary evaporator and the product is washed twice with 30 ml of diethyl ether (total 60 ml of diethyl ether).
• Another aspect of this invention provides a method of labeling oligonucleotides.
• the method comprises the step of reacting the dye phosphoramidite of the invention described above with the oligonucleotide under conditions that allow linking of the dye phosphoramidite to the oligonucleotide.
• One skilled in the art can work out the labeling conditions without undue experimentation in view of the disclosure of the present invention.
• the phosphoramidites of dyes of the present invention can be introduced anywhere in the sequence.
• the preferred point of addition, however, is the 5 '-end of the oligonucleotide, where interference with hybridization by the dye label is minimized. Addition of a second dye is possible by using commercially available linkers thus providing a multi-color labeled oligonucleotide.
• This invention provides, therefore, stable and convenient labels for fluorescent detection of biomolecules.
• the labels can be added to an oligonucleotide in a single automated step on any DNA synthesizer and do not require previously used protection-de- protection steps.
• oligonucleotides labeled with phosphoramidites of dyes of the present invention may be used as fluorescent hydridization probes to identify the presence and quantity of specific complementary nucleotide sequences in samples containing DNA or RNA.
• cyanine dye labels are provided in the pending U.S. application serial number 09/100,150, entitled “Efficient Activated Cyanine Dyes," U.S. Pat. No. 5,627,027, entitled “Cyanine Dyes as Labeling Reagents for Detection of Biological and Other Materials by Luminescence Methods," U.S. Pat. No. 5,569,587, entitled “Method for Labeling and Detecting Materials Employing Luminescent Arylsulfonate Cyanine Dyes,” the relevant contents of which are incorporated herein by reference.
• the resulting intermediate was mixed with l-(r-hydroxylhexyl)-2,3,3-trimethyl-indolinium bromide or 1-(1'- hydroxylhexyl)-l,l,2-trimethyl-benz(e)indolinium bromide (3.00 mmol) and pyridine (50 mL) and stirred at 125°C for 1 hr. Reaction was cooled to room temperature and concentrated. The crude product was washed three times with diethyl ether and purified by flash chromatography (EtOAc, acetone, MeOH, CH 2 C1 2 .
• the progress of the reaction was monitored by UN-VIS at 778 nm.
• the reaction mixture was cooled to room temperature.
• the solvents were evaporated under vacuum to dryness.
• the residue was washed three times with 50 ml of diethyl ether (total of 150 ml) to yield 1 J 6 gm (74%.) of the product.
• 1 J 6 g of the obtained compound was placed in a round bottom flask and 60 ml of anhydrous DMF and ⁇ aSC 2 H 5 (20 equivalents) were added.
• the reaction mixture was heated and incubated at 100-110°C for 2-3 hours.
• the progress of the reaction was monitored by UN- VIS at 748 nm.
• the reaction mixture was cooled and evaporated to dryness under vacuum.
• the obtained residue was triturated with CHC1 3 .
• the residue was purified on silica gel column in CH 2 C1 2 . Elution with
• the desired labeled oligonucleotide was obtained using A pac , G ⁇ r"pac , C ac and T phosphoramidite on an automated DNA synthesizer (oligo 1000M or ABI 392). 100 mg of the dye phosphoramidite was dissolved in 1ml of acetonitrile (OJM solution) and placed in the DNA synthesizer. The dye phosphoramidite was coupled for 10 minutes. After the synthesis, the oligonucleotide was cleaved and deprotected using NH OH or 0.05 M
• oligonucleotide was isolated by reverse phase HPLC (Beckman HDLL Gold System) using a Cl 8 column. Buffers A (0.1 M NH 4 OAc, pH 7.0) and B (100% acetonitrile) were used. Gradients of 0-50%> B in A were employed: 0-20 min gradient to 15%B, 20-25 min gradient to 25%B, 25-32 min gradient to 50%B, 32-37 min 50%B, 37-38 min 0%B ( Figures 15A and 15B). The elute from HPLC was evaporated to complete dryness and then dissolved in water.

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Biochemistry (AREA)
• General Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Investigating Or Analysing Biological Materials (AREA)
• Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
• Indole Compounds (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Priority Applications (2)

Applications Claiming Priority (2)

Publications (1)

Family

ID=24854600

Family Applications (1)

Country Status (4)

Families Citing this family (12)

Citations (5)

Family Cites Families (11)

• 2000
  • 2000-11-09 US US09/710,575 patent/US6331632B1/en not_active Expired - Lifetime
• 2001
  • 2001-11-02 WO PCT/US2001/045286 patent/WO2002038679A1/en not_active Ceased
  • 2001-11-02 EP EP01989818A patent/EP1339799A1/en not_active Ceased
  • 2001-11-02 JP JP2002542003A patent/JP4836395B2/ja not_active Expired - Lifetime
• 2008
  • 2008-06-06 JP JP2008149964A patent/JP2009008673A/ja active Pending

Patent Citations (5)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events